Medicinal Chemistry Research

, Volume 26, Issue 10, pp 2432–2442 | Cite as

Synthesis and anticancer activity evaluation of a quinoline-based 1,2,3-triazoles

  • Krzysztof MarciniecEmail author
  • Małgorzata Latocha
  • Rafał Kurczab
  • Stanisław Boryczka
Original Research


A small library of methylthio- or methylseleno-quinolyl-linked 1,4-disubstituted 1,2,3-triazole conjugates has been synthesized from the halogenopropargylthio- or halogenopropargylseleno-quinolines through one-pot click reaction. The ability of all of the synthesized compounds to inhibit the proliferation of the C-32, T-47D, and SNB-19 cell lines was determined using the WST-1 assay. The cytotoxic properties of these new, modified derivatives of quinolyl-triazoles were comparable to those of cisplatin. Two of them, 1-benzyl-4-[methylseleno-(6-chloro-4-quinolyl)]-1H-1,2,3-triazole (2e) and 1-benzyl-4-[methylseleno-(8-bromo-4-quinolyl)]-1H-1,2,3-triazole (2j) demonstrated significant activity on the C-32 and SNB-19 cell lines.


1,2,3-triazole Quinoline Anticancer activity CuAAC 



This research was supported by the Medical University of Silesia, grant No. KNW-1–006/K/6/O.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. Afzal O, Kumar S, Haider MR, Rahmat M, Kumar R, Jaggi M, Bawa S (2015) A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem 97:871–910CrossRefPubMedGoogle Scholar
  2. Agalave SG, Maujan SR, Pore VS (2011) Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J 6(10):2696–2718CrossRefPubMedGoogle Scholar
  3. Alvarez R, Velazquez S, San-Felix A, Aquaro S, De Clercq E, Perno CF, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-3’-spiro-5”-(4”-amino-1”,2”-oxathiole 2”,2”-dioxide) (TSAO) analogs: synthesis and anti-HIV-1 activity. J Med Chem 37(24):4185–4194CrossRefPubMedGoogle Scholar
  4. Chaudhary PM, Chavan SR, Shirazi F, Razdan M, Nimkar P, Maybhate SP, Likhite AP, Gonnade R, Hazara BG, Deshpande MV, Deshpande SR (2009) Exploration of click reaction for the synthesis of modified nucleosides as chitin synthase inhibitors. Bioorg Med Chem 17:2433–2440CrossRefPubMedGoogle Scholar
  5. Crowley JD, Bandeen PH, Hanton LR (2010) A one pot multi-component CuAAC “click” approach to bidentate and tridentate pyridyl-1,2,3-triazole ligands: synthesis, X-ray structures and copper(II) and silver(I) complexes. Polyhedron 29:70–83CrossRefGoogle Scholar
  6. Foley M, Tilley L (1998) Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79(1):55–87CrossRefPubMedGoogle Scholar
  7. Jordão AK, Afonso PP, Ferreira VF, de Souza MC, Almeida MC, Beltrame CO, Paiva DP, Wardell SM, Wardell JL, Tiekink ER, Damaso CR, Cunha AC (2009) Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture. Eur J Med Chem 44:3777–3783CrossRefPubMedGoogle Scholar
  8. Kamal A, Shankaraiah N, Devaiah V, Laxma Reddy K, Juvekar A, Sen S, Kurian N, Zingde S (2008) Synthesis of 1,2,3-triazole-linked pyrrolobenzodiazepine conjugates employing’click’ chemistry: DNA-binding affinity and anticancer activity. Bioorg Med Chem Lett 18:1468–1473CrossRefPubMedGoogle Scholar
  9. Marciniec K, Latocha M, Boryczka S, Kurczab R (2014) Synthesis, molecular docking study, and the antiproliferative action of a new group of propargylthio- and propargylselenoquinolines. Med Chem Res 23:3468–3477CrossRefGoogle Scholar
  10. Pokhodylo N, Shyyka O, Matiychuk V (2014) Synthesis and anticancer activity evaluation of new 1,2,3-triazole-4-carboxamide derivatives. Med Chem Res 23:2426–2438CrossRefGoogle Scholar
  11. Polański J, Zouhiri F, Jeanson L, Desmaele D, d’Angelo J, Mouscadet J, Gieleciak R, Gasteiger J, Bret ML (2002) Use of the kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines. J Med Chem 45:4647–4654CrossRefPubMedGoogle Scholar
  12. Püsküllü OM, Tekiner B, Suzen S (2013) Recent studies of antioxidant quinoline derivatives. Mini Rev Med Chem 13(3):365–372Google Scholar
  13. Rao PS, Kurumurthy C, Veeraswamy B, Kumar GS, Rao PS, Pamanji R, Rao JV, Narsaiah B (2013) Synthesis of novel 2-alkyl triazole-3-alkyl substituted quinoline derivatives and their cytotoxic activity. Bioorg Med Chem Lett 23:1225–1227CrossRefGoogle Scholar
  14. Rostovtsev VV, Green LG, Fokin VV, Sharpless KB (2002) A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew Chem Int Ed 41(14):2596–2599CrossRefGoogle Scholar
  15. Singhal N, Sharma PK, Dudhe R, Kumar N (2011) Recent advancement of triazole derivatives and their biological significance. J Chem Pharm Res 3(2):126–133Google Scholar
  16. Solomon VR, Lee H (2011) Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 18(10):1488–1508CrossRefPubMedGoogle Scholar
  17. Tripathi RP, Yadav AK, Ajay A, Bisht SS, Chaturvedi V, Sinha SK (2010) Application of Huisgen (3 + 2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]- triazoles and their antitubercular evaluations. Eur J Med Chem 45:142–148CrossRefPubMedGoogle Scholar
  18. Tullis JS, Van Rens JC, Natchus MG, Clark MP, De B, Hsieh LC, Janusz MJ (2003) The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) production. Bioorg Med Chem Let 13(10):1665–1668CrossRefGoogle Scholar
  19. Zajdel P, Partyka A, Marciniec K, Bojarski AJ, Pawłowski M, Wesołowska A (2014) Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents? Future Med Chem 6(1):57–75CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Krzysztof Marciniec
    • 1
    Email author
  • Małgorzata Latocha
    • 2
  • Rafał Kurczab
    • 3
  • Stanisław Boryczka
    • 1
  1. 1.Department of Organic ChemistryThe Medical University of SilesiaSosnowiecPoland
  2. 2.Department of Molecular BiologyThe Medical University of SilesiaSosnowiecPoland
  3. 3.Institute of PharmacologyPolish Academy of SciencesKrakówPoland

Personalised recommendations